Non-dilutive funding: up next

Thanks Tyler for yesterday’s comprehensive overview of SBIR/STTR grants.

These awards are great in themselves, allowing experimentation to be tried, ideas to be tested, and potential to be commercialized.

But they are also important because they can be leveraged: companies that do a good job using these grants to develop technologies are often well positioned to raise additional capital from other sources, to have an even greater positive impact on society.

In the next post, one example from within the VentureSouth portfolio, Altis Biosystems, will share some of its experience combining non-dilutive and equity funding to maximize its impact.